Differential cardiovascular and renal responses produced by microinjection of the κ-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1- pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 2, 2005, Pages 678-685

  Gottlieb, Helmut B ^a   Varner, Kurt J ^a   Kenigs, Velga A ^a   Cabral, Antonio M ^b   Kapusta, Daniel R ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ARGIPRESSIN; KAPPA OPIATE RECEPTOR; KETAMINE; NORBINALTORPHIMINE; SODIUM; XYLAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIURESIS; ARTICLE; BRADYCARDIA; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DIURESIS; GIANT CELL; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; KIDNEY FUNCTION; KIDNEY NERVE; MALE; MICROINJECTION; NERVE BLOCK; NERVE CONDUCTION; NONHUMAN; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; SODIUM RETENTION; SODIUM URINE LEVEL; SYMPATHETIC NERVE; URINE FLOW RATE;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; BLOOD PRESSURE; DIURESIS; HEART RATE; HEMODYNAMIC PROCESSES; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MICROINJECTIONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SYMPATHETIC NERVOUS SYSTEM;

EID: 13244265600     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.076828     Document Type: Article

References (44)

1. Ashton N, Balment RJ, and Blackburn TP (1989) κ-Opioid-induced changes in renal water and electrolyte management and endocrine secretion. Br J Pharmacol 97:769-776.
2. Arvidsson U, Riedl M, Chakrabarti S, Vulchanova L, Lee JH, Nakano AH, Lin X, Loh HH, Law PY, and Wessendorf MW (1995) The κ-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc Natl Acad Sci USA 92:5062-5066.
3. Blackburn TP, Borkowski KR, Friend J, and Rance MJ (1986) On the mechanisms of κ-opioid-induced diuresis. Br J Pharmacol 89:593-598.
4. Brooks DP, Edwards RM, DePalma PD, Fredrickson TA, Hieble JP, and Gellai M (1991a) The water diuretic effect of the α-2 adrenoceptor agonist, AGN 190851, is species-dependent. J Pharmacol Exp Ther 269:1277-1282.
5. Brooks DP, Gellai M, DePalma PD, and Edwards RM (1991b) Modulation of vasopressin antidiuretic action by α2-adrenoceptors is species specific. Am J Physiol 261:R1242-R1246.
6. Brooks DP, Giardina G, Gellai M, Dondio G, Edwards RM, Petrone G, DePalma PD, Sbacchi M, Jugus M, Misiano P, et al. (1993) Opiate receptors within the blood brain barrier mediate κ agonist-induced water diuresis. J Pharmacol Exp Ther 266:164-171.
7. Brown CH, Ghamari-Langroudi M, Leng G, and Bourque CW (1999) Kappa-opioid receptor activation inhibits post-spike depolarizing after-potentials in rat supraoptic nucleus neurons in vitro. J Neuroendocrinol 11:825-828.
8. Brown CH and Leng G (2000) In vivo modulation of post-spike excitability in vasopressin cells by kappa-opioid receptor activation. J Neuroendocrinol 12:711-714.
9. Cabral AM, Kapusta DR, Kenigs VA, and Varner KJ (1998) Central α2-mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia. Am J Physiol 275:R1867-R1874.
10. Cabral AM, Varner KJ, and Kapusta DR (1997) Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats. J Pharmacol Exp Ther 282:609-616.
11. Carter DA and Lightman SL (1984) Inhibition of vasopressin secretion by a κ-opiate receptor agonist. Neuroendocrinol Lett 6:95-100.
12. 3 subtype. J Pharmacol Exp Ther 251:461-468.
13. Deering J and Coote JH (2000) Paraventricular neurons elicit a volume expansion-like change of activity in sympathetic nerves to the heart and kidney in the rabbit. Exp Physiol 85:177-186.
14. Haselton JR and Vari RC (1998) Neuronal cell bodies in paraventricular nucleus affect renal hemodynamics and excretion via the renal nerves. Am J Physiol 275:R1334-R1342.
15. Holt V, Haarmann J, Bovermann K, Jerlicz M, and Herz A (1980) Dynorphin-related immunoreactive peptides in rat brain and pituitary. Neurosci Lett 18:149-153.
16. Jin C and Rockhold RW (1989) Effects of paraventricular hypothalamic microinfusions of kainic acid on cardiovascular and renal excretory function in conscious rats. J Pharmacol Exp Ther 251:969-975.
17. Kapusta DR (1995) Opioid mechanisms controlling renal function. Clin Exp Pharmacol Physiol 22:891-902.
18. Kapusta DR and Obih JC (1993) Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves. J Pharmacol Exp Ther 267:197-204.
19. Kapusta DR and Obih JC (1995) Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism. J Pharmacol Exp Ther 273:199-205.
20. Kapusta DR, Sezen SF, Chang J-K, Lippton H, and Kenigs VA (1997) Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci 60:PL15-PL21.
21. Kenney MJ, Weiss ML, and Haywood JR (2003) The paraventricular nucleus: an important component of the central neurocircuitiy regulating sympathetic nerve outflow. Acta Physiol Scand 177:7-15.
22. Leander JD, Hart JC, and Zerbe RL (1987) Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels. J Pharmacol Exp Ther 242:33-39.
23. Leander JD, Zerbe RL, and Hart JC (1985) Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine. J Pharmacol Exp Ther 234:463-469.
24. Mansour A, Burke RJ, Pavlic H, and Watson SJ (1996) Immunohistochemical localization of the cloned κ1 receptor in the rat CNS and pituitary. Neuroscience 71:671-690.
25. Menegaz RG, Kapusta DR, and Cabral AM (2000) Role of intrarenal alpha-2 adrenoceptors in the renal responses to xylazine in rats. Am J Physiol 278:R1074-R1081.
26. 2-adrenoceptors in the rostral ventrolateral medulla (RVLM) produces natriuresis by a renal nerve-dependent mechanism. Am J Physiol 281:R98-R107.
27. Nelson DO, Haywood JR, and Plunkett W (1986) Paraventricular nucleus control of renal function (Abstract). Fed Proc 45:392.
28. Oiso Y, Iwasaki Y, Kondo K, Takatsuki K, and Tomita A (1988) Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Neuroendocrinology 48:658-662.
29. Paxinos G and Watson C (1998) The Rat Brain in Stereotaxic Coordinates, 4th ed. Academic Press, Perth, Western Australia.
30. Poulain DA and Wakerly JB (1982) Electrophysiology of hypothalamic magnocellular neurons secreting oxytocin and vasopressin. Neuroscience 7:773-808.
31. Rimoy GH, Bhaskar NK, Wright DM, and Rubin PC (1991) Mechanism of diuretic action of spiradoline (U-62066E)-a kappa opioid receptor agonist in the human. Br J Clin Pharmacol 32:611-615.
32. Rossi NF and Brooks DP (1996) κ-Opioid agonist inhibition of osmotically induced AVP release: preferential action at hypothalamic sites. Am J Physiol 270:E367-E372.
33. Rossi NF, Kim JK, Summers SN, and Schrier RW (1997) Kappa opiate agonist RU 51599 inhibits vasopressin gene expression and osmotically-induced vasopressin secretion in vitro. Life Sci 61:2271-2282.
34. Salas SP, Roblero JS, Lopez LF, Tachibana S, and Huidobro-Toro JP (1992) [N-methyl-Tyr1,N-methl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat. J Pharmacol Exp Ther 262:979-986.
35. Salas SP, Roblero J, Ureta H, and Huidobro-Toro JP (1989) Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action. J Pharmacol Exp Ther 230:992-999.
36. Schramm LP, Strack AM, Platt KB, and Loewy AD (1993) Peripheral and central pathways regulating the kidney: a study using pseudorabies virus. Brain Res 616:251-262.
37. Slizgi GR and Ludens JH (1986) Role of ADH in ethylketocyclazocine- induced diuresis: studies in the Brattleboro rat. Life Sci 38:2437-2440.
38. Strack AM, Sawyer WB, Platt KB, and Loewy AD (1989) CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus. Brain Res 491:274-296.
39. Swanson LW and Kuypers HG (1980) The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol 194:555-570.
40. Toney GM, Chen QH, Cato MJ, and Stocker SD (2003) Central osmotic regulation of sympathetic nerve activity. Acta Physiol Scand 177:43-55.
41. 2-adrenoreceptors to kappa opioid agonist-induced water diuresis in the rat. J Pharmacol Exp Ther 270:244-249.
42. Watson SJ, Akil H, Fischli W, Goldstein A, Zimmerman E, Nilaver G, and Van Wimersma Griedanus TB (1982) Dynorphin and vasopressin: common localization in magnocellular neurons. Science (Wash DC) 216:85-87.
43. Yamada K, Imai M, and Yoshida S (1989) Mechanism of diuretic action of U-62066E, a κ-opioid receptor agonist. Eur J Pharmacol 160:229-237.
44. Zho B-G, Chapman C, and Bicknell RJ (1988) Functional κ-opioid receptors on oxytocin and vasopressin nerve terminals isolated from the rat neurohypophysis. Brain Res 462:52-66.